Confronto
Carbetocin vs. Linaclotid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
37025-55-1
851199-59-2
Peso molecolare
nessun dato
1526.74 g/mol
Emivita
0.67 h
nessun dato
Sequenza
nessun dato
nessun dato
Meccanismo d'azione
Carbetocin
Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.
Linaclotid
Linaclotide activates the guanylate cyclase-C receptor on the luminal surface of the intestinal epithelium. This raises cyclic GMP (cGMP), increases secretion of chloride and bicarbonate into the lumen, raises stool fluid content and accelerates transit; pain signaling is also modulated.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
1
0
di cui sull'uomo
1
0
Effetti registrati
2
2
Contraddizioni aperte
0
0
Eventi avversi documentati
1
1
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Carbetocin and Linaclotid?
- Carbetocin is classified as "Ricerca (altro)", while Linaclotid is classified as "Ricerca (altro)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Carbetocin or Linaclotid?
- The highest available evidence level is "RCT sull'uomo" for Carbetocin and "RCT sull'uomo" for Linaclotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Carbetocin and Linaclotid in Germany and the United States?
- Germania: Carbetocin — Su prescrizione, Linaclotid — Su prescrizione. Stati Uniti: Carbetocin — Non approvato, Linaclotid — Su prescrizione. These are factual summaries with source and review date on the individual pages.